Exam 5 Flashcards
Intrinsic apoptosis
Initiated by perturbations of the extracellular or intracellular microenvironment, demarcated by MOMP, and precipitated by executioner caspases, mainly C3 
Extrinsic apoptosis
Initiated by perturbations of the extra cellular microenvironment detected by plasma membrane receptors, propagated by C8, and precipitated by executioner caspases, mainly C3
Autophagy-dependent cell death
Mechanistically depends on the autophagic machinery
Necroptosis
Triggered by perturbations of extracellular or intracellular homeostasis that critically depends on MLKL, RIPK3, and kinase activity of RIPK1
Ferroptosis
Initiated by oxidative perturbations of the intracellular microenvironment that is under control by glutathione peroxidase (GPX4), can be inhibited by iron chelators or lipophilic antioxidants
Caspase target MST1
Chromatin condensation
Caspase target ICAD (inhibitor of a DNase)
DNA cleavage
Caspase target Lamins
Nuclear envelope breakdown
Caspase target Rho Kinase
Actin cytoskeleton disruption
Caspase target cell-cell and cell-ECM adhesion junctions
Cell rounding and deattachment (blebbing)
Caspase target golgi and ER proteins
Fragmentation of organelles
Caspase target eIFs
Translation arrest
Caspase triggering externalization of phosphatidyl serine
“Eat me” to phagocytic white blood cells
How does membrane blebbing occur?
Process of ROCK (Rho-associated kinase) leads to actin bundle contraction and membrane blebbing
How does chromatin condensation occur?
Proteolysis of the protein kinase MST1 releases an active fragment that phosphorylates histamine 2B and promotes condensation
Initiator Caspases
C 9, 2, 8, 10
Activated in protein complexes, the nature is site-dependent (Close together perpetuates signals Causing DISCs assemble a plasma membrane receptors, and PIDDosomes appear to interact with mitotic machinery)
Effector caspases
C 3, 7, 6
Apoptosome
A protein complex that activates C9
DISC
Death inducing signaling complex (activates C8 and C10) 
PIDDosome
A Caspase-activating protein complex that includes p53 induced death domain protein (activates C2)
Mitotic spindle problems involving kinetochores and spindle poles activate C2 which activates PIDDosomes —> hydrolyze Mdm2 —> inducing p53 activity 
Extrinsic pathway of Caspase activation
Death ligand binds to death receptor, FasL to Fas, Which creates the DISC Intracellularly: includes scaffolding which can then bind and activate C8  —> C3 —> apoptosis
Intrinsic pathway of Caspase activation
Involves damage or stress, which is transmitted to the mitochondria, resulting in MOMP and release of cytochrome C —> set a currency forms a complex with a PAF1 and C9 (apoptosome) —> Activates C9 —> C3
Inhibit MOMP and suppress apoptosis
• Bcl-2
• Bcl-xL
Promote MOMP and promote apoptosis
• Bax
• BAK
BH1,2,3 protein
Inhibit Bcl-2 and Bcl-xL and promote apoptosis
• Bid, Bad
• Puma, Noxa
BH3-only protein
IAPS: Inhibitor of apoptosis proteins
Bind to caspases and directly inhibit their proteolytic activity
Smac/Diablo
Released by mitochondria after MOMP, these proteins can inhibit IAPs 
AIF: Apoptosis inducing factor
A nucleus that is released by mitochondrial MOMP that can translocate the nucleus and cleave DNA, resulting in cell death, independent of caspases
ER stress transduced into apoptotic response
Activate C12 —> C9 —> Rest of Caspase cascade
DNA damage transduced into apoptotic response
• Damage detected by ATM/ATR kinases
•  activates Chk1/2 —> Stabilizes p53
• p53 Target Bax, which promotes MOMP, cytochrome C release, formation of apoptosomes leading to apoptosis
What keeps Bcl-2 free from inhibition by proapoptotic Bcl-2 family members?
PKB/Akt regulated by PI3K
Autophagy
Provides bulk degradation and recycling of cytoplasmic components in lysosomes promoting cell health and survival
When in excess, this compromises the cytoplasm and activates apoptosis 
• Beclin1, PI3K, Atg
AMPK responding to metabolic conditions
Promotes autophagy both by inhibiting mTOR and activating ULK1
Beclin-PI3K-Atg Complex
Receives input from mTOR (inhibits complex)
Receives input from AMPK (activates complex) 
Bcl-2 functioning as a switch between apoptosis and controlled autophagy
• binds and inhibits Beclin1, thereby restraining autophagy— if Phosphorylated by jnk, Beclin1 is free and autophagy occurs
• when bound to Beclin1, it is not bound to Bak/BAX, promoting apoptosis
Necroptosis
C8 inhibited by FLIP/pathogens -> increases RIPK1/3 -> increases MLKL (penetrates membrane w 4 alpha-helices, cell swelling) -> increases necroptosis
Necroptosis and PAMP/DAMP
Necroptosis releases PAMPs and DAMPs (Pathogen/damage associated molecular patterns), that active the inflammatory response
Ferroptosis
decrease GPX4, increase accumulation of ROS. Lipid peroxidation in the associated rupture of cellular membranes is a hallmark of ferroptosis
• occurs with age in Lipofuscin granules, Fenton rxns
(1) death receptor signaling at the plasma membrane
(2) Extensive DNA or organelle damage
(3) Malformed mitotic spindles was compromised function
(1) DISCs
(2) apoptosomes (cyt C, APAF1, C9)
(3) PIDDosomes
Increasing bax-mediated pore formation in mitochondrial outer membrane is most likely to result in the assembly of
Apoptosomes
A dying sell displaying an unusually large number of lysosomes is most likely undergoing:
Autophagy
Increasing the expression of which of the following proteins would be expected to make a cell more resistant to apoptosis?
Bcl-2
Cells can shift from an apoptotic response to a necroptotic response if _______ is inactivated by _________.
Caspase 8 , viral proteins (pathogens) 
What would be expected to facilitate MOMP and promote apoptosis?
Extrinsic pathway activation leading to the production of t-Bid from BID with the consequent activation of the intrinsic pathway
Protein that functions in transducing DNA damage into either cell cycle arrest or an apoptotic response, depending on the severity of the damage in the overall cell state
p53
Selection bias: Berkson Bias
Also known as collider bias, Study population selected from a hospital that can lead to spurious negative associations
Strategy to reduce bias: choice of comparison group
Selection bias: healthy worker effect
Study population is healthier than the general population
Strategy to reduce bias: study design, choice of comparison group
Selection bias: nonresponse bias
People who choose to participate are different in meaningful ways from people who choose to not participate
Strategy to reduce bias: study design
Recall bias
Awareness of disorder/disease causes people to recall potential exposures differently
Strategy to reduce bias: study design
Measurement bias
Differential versus non-differential
Hawthorne effect: participants change their behavior because they know they’re being observed
Strategies to reduce bias: choice of comparison group, use standard/validated tests/procedures, regular calibration of equipment, training of study staff
Procedure bias
Participants in different groups are not treated the same
Strategy to reduce bias: masked study design
Observer expectancy bias
Researchers preconceived ideas of results influence measurement, documentation, statisical analyses
Strategies to reduce bias: masked study design, independent statistical analyses
Confounding bias
Risk factor is related to both exposure and health outcomes, but is not casually related (Ex. Use of cod liver oil is positively associated with age related hearing loss)
Strategies to reduce bias call study design, replication studies
Lead-time bias
Early detection is confused with increased survival time
Strategies to reduce bias: study design
Survivor bias
A.k.a. incidence prevalence bias
Strategies to reduce bias: limit analysis to incident cases
Publication bias
Studies were statistically significant results are more likely to be pushed, as are those documenting a novel finding
Strategies to reduce bias: measure existence with Donald lots, include novel sources to identify data for meta-analyses 
Example of a common genetic polymorphism
Rh system: (+) and (-)
Alpha1-antitrypsin (ZZ)
Major serum protein that inhibits proteolytic enzymes, major target is leukocyte elastase which can damage lung connective tissue if not down regulated— Early onset emphysema 
Ecogenetics
Genetic variation in susceptibility to environmental agents
Examples: fair complexion and UV light, ADH deficiency and alcohol, G6PD deficiency and fava beans
Heterozygous advantage
A deleterious allele that is maintained in a population because it increases reproductive fitness when it is heterozygous — Ex. Sickle cell
 Hardy Weinberg law
1.) there is no appreciable rate of new mutation
2.) Individuals with all genotypes are equally capable of mating and passing on their genes— no selection against any particular genotype
3.) No significant immigration of individuals from a population with allele frequencies very different from the endogenous population
Hardy Weinberg equation
p^2 + 2pq + q^2
p^2: probability of AA genotype
q^2: probability of aa genotype
pq: heterozygous
p= 1-q
Importance of Hardy Weinberg disequilibrium
When alleles at a locus are not in HW equilibrium this can indicate that a particular allele is associated with a disease— fatal/ doesn’t show up as frequently in a community
Mendelian diseases
Primary single gene diseases, the disruption of a single gene
The most common functional protein change mutation
Loss of function— Miss sense, nonsense, frameshift, deletions, insertions
Gain of function mutations
Increase gene dosage/proteins function
Ex. Down syndrome, achondroplasia
Allelic heterogeneity
Different alleles of the same gene/locus causing very disease severity
— PKU
Locus heterogeneity 
Mutations in different genes/locus is can yield a similar clinical phenotype 
— hyperphenylalaninemia 
Modifier genes
People with the same mutation can present dramatically different phenotypes due to the presence of modifier genes
Ex: ApoE4 frequency increasing neurological and neurodegenerative disorders
Example of enzyme defect
PAH gene and the disease PKU— Also an example of defect that occurs in one tissue (liver, kidney) but where the phenotype is manifest elsewhere (brain)
Defects in lysosomal storage
Leads to increased tissue mass and is a common cause of neurodegeneration and CNS problems
Example: Tay-Sachs disease buildup of GM2 gangliosides sphingolipids in the retina lysosomes
Defects in protein trafficking
I-cell disease: autosomal recessive lysosomal storage disease caused by a defect in proteins trafficking, acid hydrolases which are required are not properly modified with glycoproteins
Acid hydrolases get sent out of the cell instead of to the lysosomes
Defect in cofactor metabolism example
Alpha 1-AT : Involved in the breakdown of various proteases that can damage lung tissue if not regulated. (Interaction with environmental factors like cigarette smoke) 
Defect in receptor proteins example
Hypercholesterolemia: LDLR defect, causes cardiovascular disease
Defect in transport examples
Cystic fibrosis, delta F508, Mutation of a chloride channel, affects lungs and exocrine pancreas
Defects in structural proteins example
DMD: X-linked recessive disease caused by a mutation in the dystrophin gene
Female carrier: elevated creatine kinase levels, no clinical manifestation
Triple repeat expansion disorders
Huntington’s, fragile X, Friedreich ataxia, myotonic dystrophy 1 and 2
Mitochondrial genetic bottleneck
The restriction and subsequent amplification of mtDNA during oogenesis: mosaicism/heteroplasmy
Mothers with a high proportion of mutant mtDNA are more likely to have clinically affected offspring
Complex genetic diseases
Do not demonstrate a simple Mendelian pattern of inheritance, often demonstrate familial aggregation, inheritance is more common among the close relatives of a proband, more likely in MZ versus DZ twins
Human characteristics which show a continuous normal distribution
• blood pressure
• dermatoglyphics
• head circumference
• height
• IQ
• skin color 
Four characteristics of inheritance of complex diseases
1.) no simple Mendelian pattern of inheritance
2.) Familial aggregation
3.) Environmental factors
4.) More common among close relatives of the proband 
Relative risk ratio
Prevalence of the disease in the relatives of an infected person
___________________________________
Prevalence of the disease in the general population
Odds ratio
OR=1 would show complete lack of association
OR>1 A higher risk of an outcome
OR<1 Lower risk of an outcome
Examples of recurrence risks and relative risk ratios
Schizophrenia, bipolar disorder, coronary artery disease, MI, Alzheimer’s disease
Approaches to identifying genes underlying complex diseases
1.) Test a candidate gene for variance in a disease population
2.) map a gene in a family/families with history of disease
Quantitative trait loci (QTLs) 
Complex disease genes identified often have quantitative affects
Physical mapping of disease genes
Actual sequence and physical location on a chromosome are being looked at
Genetic mapping for disease genes
Based on the following a phenotypic trait in the families, indicates the relative position of genes (as identified by their function) as shown by linkage analysis
Linkage analysis
Uses statistics to determine whether to genes, loci or the markers they are based on, are likely to live near one another. Estimated by the frequency that they are transmitted together
Two genetic loci are linked if they are transmitted together from parent to offspring more often than expected under independent inheritance
Recombination frequency
RF > 50% means two genes are unlinked
RF < 50% means two genes are linked
Mendel’s first law
The principle of segregation: the two members of a gene pair segregate from each other in the formation of gametes. Half of the gametes carry one allele, and the other half carry the other allele
Mendel’s second law
The principle of independent assortment: genes for different traits assort independently of one another in the formation of gametes. —unlinked 
A disease locus can be mapped by:
Following its co-transmission with known chromosomal markers (Without knowledge of the actual gene)
LOD scores
Logarithm of the odds: odds ratio is expressed as the log10 of this ratio
— this is the likelihood of data if loci are linked
LOD of 3+ : 1000:1 odds favor of linkage (not random)
Association analysis
Start with a candidate gene, suspect that a defect or polymorphism is responsible and then look into families and or population to determine if people with a disease are statistically more likely to carry a particular rotation or polymorphism
Steps in mapping a complex disease gene
• linkage analysis/prior knowledge
• Genomic analysis, association analysis to determine the correspondence
•  alternative strategy: SNP chips
• Follow up with bio chemical and molecular analysis/animal models
Calpain-10 (CAPN10)
A type two diabetes gene, found by linkage analysis of Mexican American family
— Is not a polymorphic marker, is actually the disease. Assisting protease that interferes with insulin secretion and glucose uptake
Sib-pair analysis
Uses small families and asks whether affected siblings share specific gene alleles had a frequency higher than expected by random chance
 Comparing identical by descent (IBD) to identical by state (IBS)
Identical by descent
Siblings have the same allele from the same parent
Identical by state
Siblings have the same allele, regardless of what parent it came from
Hirschsprung disease and Sib-Pairs
55/67 shared three polymorphic markers at three different genes
The other 12 shared at least two of the three polymorphic markers
— RET gene malfunction 
Sources of one-carbon units
Serine, glycine, histidine, formaldehyde, formate
Regulation of the one-carbon pool
FH4 delegating a C — formyl <—> methylene <—> methyl
Folate
• Vitamin precursor of FH4
• found in leafy green vegetables, liver, legumes, yeast, fortified flour
• has glutamic acid tail
Major form of folate in the blood
Reduced N5-methyl tetrahydrofolate from the intestinal epithelial cells
PCFT
Proton (H+) coupled folate transporter encoded on the SLC46A1 gene on enterocytes and hepatocytes
Hereditary folate malabsorption
An inherited mutation in the proton coupled folate transporter causing a functional folate deficiency despite adequate folate in the diet: no absorption 
What is a folate deficiency associated with before and during pregnancy?
Spina bifida, neural tube defects
Folate to FH4
Folate —dihydrofolate reductase—> dihydrofolate — dihydrofolate reductase—> tetrahydrofolate
What drugs target dihydrofolate reductase?
Methotrexate colon cancer, rheumatoid arthritis
Trimethoprim: antibacterial
Pyrimethamine: antimalarial
How is formate formed?
The degradation of tryptophan— Formate is one source of carbon for the “one carbon pool”
Redox of formate/tetrahydrofolate 
FH4 + formate —> N10- formyl <—> N5,N10-methenyl <—> N5,N10-methylene —> N5-methyl
Forminotransferase deficiency
FIGLU accumulation (from FH4 + histidine —> 5-formimino + glutamate) characterized by Megaloblastic anemia and mental retardation
Serine and the one carbon pool
Serine is the most important contributor to the one carbon pool. It forms N5,10- methylenetetrahydrofolate when it donates its carbon to FH4 using PLP as a cofactor
Sources of products of the one carbon pool
Serine, glycine, Choline, Histidine, tryptophan
Two forms of B12 in the body
Methylcobalamin
Adenosylcobalamin 
Methylcobalamin reaction:
Donation of a methyl to homocystine to make methionine
— Methylcobalamin is consumed in the process
Adenosylcobalamin reaction:
Catalyzes the isomerization of a methyl group in converting methylmalonyl CoA to succinylacetone CoA 
— catabolism of branched chain an odd chain length fatty acids, isoleucine, valine
— Adenosylcobalamin not consumed in the reaction
How B12 enters the body
1.) binds to R binder proteins in the stomach
2.) R binders get digested, B12 then binds to intrinsic factor
3.) Intrinsic factor B12 complex is taken up by intestinal epithelial cells and transported into the blood
— Transcobalamin II is the protein used
4.) B12 get stored in the liver complex with Cubillin
B12 deficiency
• Causes pernicious anemia, megaloblastic anemia plus neurological problems
• caused from dietary deficiency, loss of function of intrinsic factor, transcobalamin II, or cubillin 
What is S – adenosylhomocystine used for?
SAM — A methyl donor for many biosynthetic and regulatory enzymes, and it must be regenerated with carbon that comes from N5-methyltetrahydrofolate
Methotrexate
Targets dihydrofolate reductase,
FH2 —x—> FH4
Folate deficiency leads to decrease in nucleotide production. Use against cancer, because those cells require deoxynucleotides for rapid cell division
5–fluorouracil
A uracil analog that inhibits thymidylate synthase. Is a suicide inhibitor
dUMP—x—> dTMP
Folate deficiency leads to decrease in nucleotide production. Use against cancer, because those cells require deoxynucleotides for rapid cell division
Hyperhomocystinemia
Accumulation of homocystine because it cannot be converted to methionine by B12 (Methylcobalamin)
This can also be caused by a vitamin B6 deficiency, because the homocysteine cannot convert to cysteine 
Betaine
This is the bodies second pathway to turn homocysteine to methionine. It is a metal donor
The buildup of homocysteine affects: 
• PNS & CNS deficiencies
• atherosclerosis
• Osteoporosis
— Interferes with collagen maturation 
Methylmalonyl CoA mutase activity lost (Adenosylcobalamin def) causes:
Inappropriate synthesis causing branched chain fatty acids rather than unbranched. These branched fatty acids compromise the membrane structure
Methyl trap hypothesis
The only metabolic fate of N5-methyl FH4 is to lose its methyl to cobalamin. In a dietary or functional deficiency, folate becomes trapped as N5-methyl FH4, unable to participate in other one carbon transfers
Clinical features of cobalamin deficiency
Megaloblastic Anemia, sore tongue, auto immune gastritis, numbness and ataxia
Severe osteoporosis and young patient should always suggest the possibility of what?
Homocystinuria
The two main processes of tissue repair
1.) regeneration: restoration of normal cells
2.) Scarring/fibrosis: deposition of connective tissue
Ultimate repair is usually a combination of both
Mechanisms of regeneration of tissue
1.) proliferation of differentiated cells that survive injury and have ability to proliferate (ex. Liver)
2.) Tissue stem cells produce new and differentiated cells (ex. Skin, GI)
— Regeneration typically requires intact supporting structures
Mechanism of scarring/fibrosis of tissue
1.) injured area is patched with connective/fibrous tissue. Occurs when cells are not capable of regeneration, or supporting structures are too severely damaged
2.) functional cells are replaced by connective tissue, which provides structure but does not provide function
Three classes of tissues that can be repaired
1.) labile, constantly dividing tissue
2.) Stable tissue
3.) Permanent tissue
Labile, constantly dividing tissue
• Constant overturn fed by stem cells and proliferation of mature cells
• Occurs in the lung, skin, G.I. tract, and hematopoietic
• surface of the epithelia 
Types of labile cells
• Type two pneumocyte in the lung
• basal cell in the skin
• Crypt cells in the G.I. tract
• CD34+ cells
Stable tissue
• made of quiescent cells (G0)
• Capable of proliferating when tissue is injured or lost
— In solid tissues: liver, kidney pancreas
— in connective tissue: endothelium, smooth muscle, fibroblasts
Permanent tissue
• cells are terminally differentiated and cannot proliferate
• This includes most neurons, cardiac, and skeletal muscle
• Repair is almost entirely scarring/fibrosis
Regeneration after injury is driven by:
Growth factors derived from:
• Active macrophages at the side of injury (most common)
• Platelets
• Epithelial cells
• Stromal cells (Fibroblasts)
• Sequestered pool in extracellular matrix
Heparan sulfate
An extra cellular matrix signaler for tissue damage 
Phase 1 of scarring/fibrosis repair
Inflammatory (days 1-3)
• Cellular mediators: platelets, neutrophils, macrophages
• Actions: acute inflammatory responses
Phase 2 of scarring/fibrosis repair
Proliferative (day 3-weeks)
• Cellular mediators: fibroblasts, myofibroblasts, endothelial cells, epithelial cells, macrophages
• actions: establishment of granulation tissue, angiogenesis, epithelial cell proliferation, type III collagen deposition
Phase 3 of scarring/fibrosis repair
Remodeling (1 week- months)
• Cellular mediators: fibroblasts
• Actions: type III collagen deposition replaced by type I collagen (stiffer, less elastic) 
Granulation tissue
Many new blood vessels, fibroblasts, and chronic inflammation including numerous macrophages
Angiogenesis: action of VEGF
Vascular endothelial growth factor:
• Stimulates both migration and proliferation of endothelial cells
• Promotes vasodilation by stimulating the production of NO
• Contributes to the formation of vascular lumen
(Important for healing) 
Angiogenesis growth factors
FGF, TGF-beta, VEGF,
Fibrosis growth factors
TGF-beta, PDGF
Vascular remodeling and smooth muscle migration growth factor
PDGF
Cell proliferation and regeneration growth factor
EGF
Central role of the macrophage
M1: clearing offending agents and dead tissue
M2:
• Provide growth factors causing the proliferation of various cells
• Secrete cytokines that stimulate fibroblasts to proliferate and deposit connective tissue in ECM
Temporally regulated
Initially, the macrophages are classically activated (M1), but are gradually replaced by alternately activated type (M2)
TGF-beta
• produced by cells in granulation tissue
• Stimulus fibroblast migration and proliferation
• Increases synthesis of collagen and fibronectin
• decreases degradation of ECM
• Has anti-inflammatory properties
Clinical factors that can impede repair
INFECTION, diabetes, nutritional deficiencies, medication/steroids, mechanical stress, ischemia/poor perfusion, foreign material, injury type and extent, injury location
First intention wound
A suture surgical incision with tightly apposed edges
Second intention wound
A wide open wound, which leads to more inflammation, more granulation tissue, increased risk of infection, large scar
myofibroblastic contraction plays a major role in wound closing
Wound strength
At one week: wound is about 10% as strong as normal skin
After two months: maximum strength is achieved, still only 75% of the original tissue strength
Hypertrophic scar
Raised, limited to boundaries of original wound, tends to regress overtime, parallel collagen I bundles as in normal scar
Keloid scar
Markedly raised, expands beyond the boundaries of the original wound, contains bright eosinophillic collagen bundles that are disorganized
Scar contracture
Failure to make a scar, the fibroblasts pull the skin back together and it pulls too tightly
Leak channels:
Always open, help maintain resting membrane potential, permeate K more than Na
Voltage gated channels
Activated by membrane potential: Na, Ca, K, Cl channels 
Extracellular ligand activated channels
Regulated by ligands (neurotransmitters), glutamate, GABA, and glycine receptor channels
Intracellular ligand gated ion channels
Activated by Ca2+, ATP, cyclic AMP and GMP, often activated indirectly by GPCRs including CFTR and ABC transporters
Thermos sensitive channels
Regulated by temperature and pain, TRP channels
Mechano-sensory and volume regulated channels
Activated by touch, hearing, cardiovascular regulation, sensing of gravity, and osmotic stress
Light gated channels
Used for Optogenetics
Channelrhodopsin: blue light (Na+,K+)
Halorhodopsin: yellow light (Cl-)
Types of gated ion channels
1.) Confirmational change in one region
2.) General structural change
3.) Blocking particle (AA)
4.) ligand gated
5.) Phosphorylation gated
6.) Voltage gated
7.) Stress or pressure gated (Cytoskeleton)
Mechanisms for channel inactivation
1.) change in membrane potential
2.) Calcium binding
3.) Dephosphorylation
Which channel type is the most diverse?
K+
— they can be sensitive to depolarization, hyper polarization, pH, and change in intracellular Ca2+ 
Equilibrium of K+
-58mV
The action potential
Na channel
1.) resting potential, leak K channel, -60mV
2.) Rising phase, opening Na channels
3.) Overshoot phase, Na close, K open
4.) Falling phase, K opens maximally
5.) Under shoot phase: refractory because K is slow to close
Action potential of cardiac muscle
0.) Rapid influx Na+ through open fast Na+ channels
1.) Transient K channels open and K efflux returns TMP to 0mV
2.) inflow of Ca2+ through L-type Ca2+ channels is electrically balanced by K efflux through delayed rectifier K channels
3.) Ca2+ channels close but delayed rectifier K channels remain open and return TMP to -90mV
4.) Na+, Ca2+ channels closed, open K rectifier channels keep TMP stable at -90mV
Long QT syndrome
Loss of K channels, dangerous because no recovery before another spike
Symptoms: torsades de pointes, syncope, seizures, sudden death
Purines are constructed by:
Adding atoms from formyltetrahydrofolate, glutamine, glycine, aspartate, and CO2 sequentially to PRPP
Pyrimidines are constructed by:
Building the orotate base from aspartame, CO2, and glutamine. The base is then transferred to PRPP and further modified to cytosine, thymidine, or uracil
PRPP
An activated ribose sugar created by transfer of pyrophosphate to ribose-5-phosphate by PRPP synthetase (KEY REGULATORY STEP!)
PRPP synthetase is allosterically inhibited by purine diphosphonucleosides (GDP, ADP)
IMP is synthesized by
N10-formyl FH4 (twice)
IMP + aspartate + GTP
AMP (+ fumarate)—>ADP—>dADP—>dATP—>DNA
Or
AMP—>ADP—> ATP—> RNA
IMP + glutamine + ATP
XMP—> GMP—> GDP—> GTP —> RNA
or
XMP—> GMP—> GDP—> dGDP—> dGTP—> DNA
Ribonucleotide reductase uses what as substrates?
Nucleotide diphosphate (ADP, GDP)
Purine salvage: free bases to nucleotides and back
Converting free bases to nucleotides, using APRT & HGPRT (Phosphoribosyltransferases that add ribose form PRPP)
Hypoxanthine (HGPRT)—> IMP
Guanine (HGPRT)—> GMP
Adenine (APRT)—> AMP
Purine salvage: Nucleosides to nucleotides
Purine nucleoside phosphorylase removes ribose, leaving the free base
Inosine—> hypoxanthine
Guanosine—> guanine
Purine salvage: Adenosine kinase
Adenosine can be converted to AMP directly through phosphorylation by adenosine kinase 
Gout
Precipitation of uric acid in distal joints. Caused by purine degradation leading to hyperuricemia
CPS II
Uses glutamine as an amine donor to form carbamoyl phosphate (Same product as CPS I, doesn’t use ammonia) It is allosterically inhibited by UTP and activated by PRPP
Thymidine synthase
Uses dUMP as a substrate, so dUDP has to be the phosphorylated before it can be methylated to dTMP. dTMP Is then phosphorylated twice to make dTTP, a substrate for DNA synthesis
PRPP synthetase superactivity
Inhibited by ADP, and GDP normally. Super activity loses inhibition
X-linked condition seen only in males, symptoms are due to increased purine production and increase uric acid
— Crystalluria, urinary stones, gout

ADA-SCID
Severe combined immunodeficiency resulting from adenosine deaminase deficiency (ADA— Normally removes amine group from adenosine in salvage pathway)
Leads to an accumulation of adenosine and 2-deoxyadenosine in the blood. Toxic to developing lymphocytes
— Requires hemopoietic stem cell transfer
PNP-SCID
Combined immunodeficiency resulting from purine nucleotide phosphorylase deficiency
— Requires hemopoietic stem cell transfer